Liminatus Pharma, Inc. Class A Common Stock (LIMN)
LIMN Stock Price Chart
Explore Liminatus Pharma, Inc. Class A Common Stock interactive price chart. Choose custom timeframes to analyze LIMN price movements and trends.
LIMN Company Profile
Discover essential business fundamentals and corporate details for Liminatus Pharma, Inc. Class A Common Stock (LIMN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 May 2025
Employees
3.00
Website
https://liminatuspharma.comCEO
Chris Kim
Description
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
LIMN Financial Timeline
Browse a chronological timeline of Liminatus Pharma, Inc. Class A Common Stock corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Jun 2026
Earnings released on 15 May 2026
EPS came in at -$0.03 .
Earnings released on 31 Mar 2026
EPS came in at -$0.03 .
Earnings released on 13 Nov 2025
EPS came in at -$0.07 .
Earnings released on 3 Oct 2025
EPS came in at -$0.05 .
LIMN Stock Performance
Access detailed LIMN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
